Durable Responses and Survival in High-risk Myelodysplastic Syndrome and Acute Myeloid Leukemia Patients Receiving the Allogeneic Leukemia-derived Dendritic Cell Vaccine DCP-001

Luca L. G. Janssen; Theresia M. Westers; Jeroen Rovers; Peter J. M. Valk; Jacqueline Cloos; Tanja D. de Gruijl; Arjan A. van de Loosdrecht

doi:https://doi.org/10.1097/HS9.0000000000000968

Durable Responses and Survival in High-risk Myelodysplastic Syndrome and Acute Myeloid Leukemia Patients Receiving the Allogeneic Leukemia-derived Dendritic Cell Vaccine DCP-001

Luca L. G. Janssen, Theresia M. Westers, Jeroen Rovers, Peter J. M. Valk, Jacqueline Cloos, Tanja D. de Gruijl, Arjan A. van de Loosdrecht

Research output: Contribution to journal › Letter › Academic › peer-review

Original language	English
Pages (from-to)	E968
Journal	HemaSphere
Volume	7
Issue number	11
DOIs	https://doi.org/10.1097/HS9.0000000000000968
Publication status	Published - 2 Nov 2023

Access to Document

https://doi.org/10.1097/HS9.0000000000000968

Cite this

Janssen, L. L. G., Westers, T. M., Rovers, J., Valk, P. J. M., Cloos, J., de Gruijl, T. D., & van de Loosdrecht, A. A. (2023). Durable Responses and Survival in High-risk Myelodysplastic Syndrome and Acute Myeloid Leukemia Patients Receiving the Allogeneic Leukemia-derived Dendritic Cell Vaccine DCP-001. HemaSphere, 7(11), E968. https://doi.org/10.1097/HS9.0000000000000968

@article{6bab1f1d2f4e4e5db7ef7863030ae462,

title = "Durable Responses and Survival in High-risk Myelodysplastic Syndrome and Acute Myeloid Leukemia Patients Receiving the Allogeneic Leukemia-derived Dendritic Cell Vaccine DCP-001",

author = "Janssen, {Luca L. G.} and Westers, {Theresia M.} and Jeroen Rovers and Valk, {Peter J. M.} and Jacqueline Cloos and {de Gruijl}, {Tanja D.} and {van de Loosdrecht}, {Arjan A.}",

note = "Funding Information: This work was supported by grant CCA-PV-20219-03 of Cancer Center Amsterdam.",

year = "2023",

month = nov,

day = "2",

doi = "https://doi.org/10.1097/HS9.0000000000000968",

language = "English",

volume = "7",

pages = "E968",

journal = "HemaSphere",

issn = "2572-9241",

publisher = "Wolters Kluwer Health",

number = "11",

}

Durable Responses and Survival in High-risk Myelodysplastic Syndrome and Acute Myeloid Leukemia Patients Receiving the Allogeneic Leukemia-derived Dendritic Cell Vaccine DCP-001. / Janssen, Luca L. G.; Westers, Theresia M.; Rovers, Jeroen et al.
In: HemaSphere, Vol. 7, No. 11, 02.11.2023, p. E968.

Research output: Contribution to journal › Letter › Academic › peer-review

TY - JOUR

T1 - Durable Responses and Survival in High-risk Myelodysplastic Syndrome and Acute Myeloid Leukemia Patients Receiving the Allogeneic Leukemia-derived Dendritic Cell Vaccine DCP-001

AU - Janssen, Luca L. G.

AU - Westers, Theresia M.

AU - Rovers, Jeroen

AU - Valk, Peter J. M.

AU - Cloos, Jacqueline

AU - de Gruijl, Tanja D.

AU - van de Loosdrecht, Arjan A.

N1 - Funding Information: This work was supported by grant CCA-PV-20219-03 of Cancer Center Amsterdam.

PY - 2023/11/2

Y1 - 2023/11/2

UR - http://www.scopus.com/inward/record.url?scp=85180979685&partnerID=8YFLogxK

U2 - https://doi.org/10.1097/HS9.0000000000000968

DO - https://doi.org/10.1097/HS9.0000000000000968

M3 - Letter

C2 - 37928626

SN - 2572-9241

VL - 7

SP - E968

JO - HemaSphere

JF - HemaSphere

IS - 11

ER -

Durable Responses and Survival in High-risk Myelodysplastic Syndrome and Acute Myeloid Leukemia Patients Receiving the Allogeneic Leukemia-derived Dendritic Cell Vaccine DCP-001

Access to Document

Other files and links

Cite this